Abstract 3301: TAK1 is a key regulator of oncogenic signaling and differentiation blockade in rhabdomyosarcoma
Anh Tuan Vuong(University of Houston), Ashok Kumar(University of Houston), Phuong T. Ho(Sungkyunkwan University), Aniket S. Joshi(University of Houston), Meghana V. Trivedi(University of Houston), Anirban Roy(University of Houston), Benny Abraham Kaipparettu(Children's Cancer Center), Tagari Samanta(Baylor College of Medicine), Meiricris Tomaz da Silva(University of Houston), Bin Guo(University of Houston), Kavya Mathukumalli(University of Houston), Raksha R. Bhat(University of Houston)
Cited by 0
Related Papers
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
|Cancer Cell|2014|860
MicroRNA-Based Diagnosis and Therapy
|International Journal of Molecular Sciences|2022|584
Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma
|Cell Reports|2016|382
Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer
|Cell Reports|2016|320
Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2013|273